Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson’s disease
Maria Kedariti, Emanuele Frattini, Pascale Baden, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

LRRK2 and Parkinson's disease: from genetics to targeted therapy
Yuri L. Sosero, Ziv Gan‐Or
Annals of Clinical and Translational Neurology (2023) Vol. 10, Iss. 6, pp. 850-864
Open Access | Times Cited: 31
A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells
Yahaira Naaldijk, Belén Fernández, Rachel Fasiczka, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 11
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease
Xuxiang Zhang, Heng Wu, Beisha Tang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
GBA1 Gene Mutations in α-Synucleinopathies—Molecular Mechanisms Underlying Pathology and Their Clinical Significance
Zuzanna Granek, Julia Barczuk, Natalia Siwecka, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2044-2044
Open Access | Times Cited: 22
The Hidden Cell-to-Cell Trail of α-Synuclein Aggregates
Sandesh Neupane, Elena De Cecco, Adriano Aguzzi
Journal of Molecular Biology (2022) Vol. 435, Iss. 12, pp. 167930-167930
Open Access | Times Cited: 25
Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson’s disease
Cheryl E. G. Leyns, Alice Prigent, Brenna Beezhold, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 14
Genetic Evidence for Endolysosomal Dysfunction in Parkinson’s Disease: A Critical Overview
Vidal Yahya, Alessio Di Fonzo, Edoardo Monfrini
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6338-6338
Open Access | Times Cited: 12
Increased glucosylsphingosine levels and Gaucher Disease in GBA1-associated Parkinson’s Disease.
Massimo Marano, Carmela Zizzo, Maria Chiara Malaguti, et al.
Parkinsonism & Related Disorders (2024) Vol. 124, pp. 107023-107023
Closed Access | Times Cited: 4
Endogenous LRRK2 and PINK1 function in a convergent neuroprotective ciliogenesis pathway in the brain
Enrico Bagnoli, Yu‐En Lin, Sophie Burel, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 5
Open Access
Effect of LRRK2 Inhibition on the Activity of Glucocerebrosidase in Patient-Specific Cells from Patients with Gaucher Disease
Tatiana Usenko, Katerina Basharova, Anastasia Bezrukova, et al.
Biochemistry (Moscow) (2025) Vol. 90, Iss. 1, pp. 99-106
Closed Access
Immune cell metabolic dysfunction in Parkinson’s disease
Julian R Mark, Malú G. Tansey
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access
Genome-Wide Association Study of Glucocerebrosidase Activity Modifiers
Emma N. Somerville, Lynne Krohn, Konstantin Senkevich, et al.
Molecular Neurobiology (2025)
Open Access
The modifying effect of mutant LRRK2 on mutant GBA1-associated Parkinson disease
S Vera, Egulsky Lian, M Elia, et al.
Human Molecular Genetics (2025)
Open Access
LRRK2 and Lipid Pathways: Implications for Parkinson’s Disease
Jasmin Galper, Woojin S. Kim, Nicolas Dzamko
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1597-1597
Open Access | Times Cited: 13
Molecular Pathways Involved in LRRK2-Linked Parkinson’s Disease: A Systematic Review
Ailyn Irvita Ravinther, Hemaniswarri Dewi Dewadas, Shi Ruo Tong, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11744-11744
Open Access | Times Cited: 12
Identification and characterization of nanobodies acting as molecular chaperones for glucocerebrosidase through a novel allosteric mechanism
Thomas Dal Maso, Chiara Sinisgalli, Gianluca Zilio, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Endogenous LRRK2 and PINK1 function in a convergent neuroprotective ciliogenesis pathway in the brain
Enrico Bagnoli, Yu‐En Lin, Sophie Burel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Rotenone Blocks the Glucocerebrosidase Enzyme and Induces the Accumulation of Lysosomes and Autophagolysosomes Independently of LRRK2 Kinase in HEK-293 Cells
Laura Patricia Perez-Abshana, Miguel Mendivil‐Perez, Carlos Velez‐Pardo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10589-10589
Open Access | Times Cited: 6
Lysosomal Pathogenesis of Parkinson's Disease: Insights From LRRK2 and GBA1 Rodent Models
Mattia Volta
Neurotherapeutics (2022) Vol. 20, Iss. 1, pp. 127-139
Open Access | Times Cited: 9
LRRK2 exonic variants are associated with lysosomal hydrolase activities and lysosphingolipid alterations in Parkinson's disease
Tatiana Usenko, Konstantin Senkevich, Katerina Basharova, et al.
Gene (2023) Vol. 882, pp. 147639-147639
Closed Access | Times Cited: 5
Identification of DOT1L inhibitor in a screen for factors that promote dopaminergic neuron survival
Jun Cui, Joseph Carey, Renee A. Reijo Pera
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 5
Diverging Parkinson’s Disease Pathology between patient-derivedGBAN370S, LRRK2G2019Sand engineeredSNCAA53TiPSC-derived Dopaminergic Neurons
Ali Fathi, Kiranmayee Bakshy, Lida Zieghami, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
A potential patient stratification biomarker for Parkinso’s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells
Yahaira Naaldijk, Belén Fernández, Rachel Fasiczka, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
LRRK2 Kinase Activity Regulates Parkinson’s Disease-Relevant Lipids at the Lysosome
Michael T. Maloney, Xiang Wang, Rajarshi Ghosh, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Lysosomal GCase (glucocerebrosidase) activity assay v1
Sara Gomes, Esther Sammler
(2024)
Open Access
Page 1 - Next Page

Scroll to top